Operations
Courier and SLA management for UK telehealth dispensing: where deliveries actually fail
The last mile is where good pharmacy operations quietly fail.
Read article →
Operations
Financial Operations
VAT for UK telehealth and online pharmacy: what's zero-rated, exempt, and standard-rated
Three VAT treatments can sit on one invoice.
Clinics
Menopause care beyond HRT: what UK telehealth services should offer when hormones aren't the answer
Why a single-product menopause pathway breaks down.
Patient Safety
Paediatric medicines cautions in UK telehealth: why most services stop at 16 or 18
Why most services set the floor above the legal minimum.
Compliance
How much does CQC registration cost for a UK digital clinic?
How CQC actually structures its fees.
Regulation
How to check the CQC register before choosing a UK clinic or dispensing partner
Why the register check comes before the commercial conversation.
Regulation
CQC inspection reports: how to read them and what they mean for a UK digital clinic
What a CQC inspection report actually contains.
Regulation
The CQC Provider Portal: a practical guide for UK digital clinics
What the CQC Provider Portal actually is.
Brands
Affiliate and partner referral channels for UK telehealth brands in 2026
Why partner channels get skipped.
Financial Operations
Subscription vs one-off pricing for UK telehealth in 2026: which model fits which vertical
Why the pricing model is a clinical decision, not just a checkout setting.
Brands
How to launch a UK PrEP telehealth service in 2026: eligibility, monitoring, and the NHS comparison
Why PrEP suits telehealth — with conditions.
Patient Safety
Isotretinoin prescribing in UK telehealth in 2026: the Pregnancy Prevention Programme and the specialist-only shift
Why isotretinoin sits apart from the rest of the acne pathway.
Clinics
How to launch a UK oral health telehealth service in 2026: mouth ulcers, oral thrush, and safe dental triage
Why oral health is a narrow but genuine telehealth opportunity.
Industry analysis
US telehealth expansion into the UK: the 2026 market-entry playbook
Why the UK is the default first international market.
Industry analysis
UK vs EU: where should an international telehealth company enter Europe first?
The 'European market' is a myth — plan for two.
Compliance
CQC's Single Assessment Framework for UK digital clinics: what changed and how to prepare
What the Single Assessment Framework actually changed.
Industry analysis
Orforglipron (Foundayo): what the first oral GLP-1 approval means for UK telehealth operators
What exactly was approved.
Operations
Demand forecasting for UK telehealth pharmacy operations: stock, staffing, and dispensing capacity
Why demand forecasting looks different in telehealth pharmacy.
Operations
Stock-outs and medicine shortages in UK telehealth: how operators actually manage supply disruption
Why supply disruption keeps recurring.
Clinics
How to launch a UK eye health telehealth service in 2026: dry eye, conjunctivitis, and safe remote triage
Why eye health is an underused telehealth vertical.
Dispensing
Packaging and tamper-evidence in UK telehealth dispensing: what the rules actually require
Why packaging is a compliance control, not a shipping decision.
Dispensing
Batch recalls and MHRA Drug Alerts in UK telehealth: how they actually reach dispensing pharmacies and patients
What a Drug Alert actually is.
Operations
Accessibility and interpreter provision in UK telehealth: what the Equality Act and CQC actually expect
Why accessibility is a compliance question, not a courtesy.
Brands
White-label blood testing: how UK clinics and brands can launch their own at-home test range in 2026
Your brand on the kit, our labs behind it — PExpo Diagnostics explained.
Compliance
Gillick competence and consent in UK telehealth: treating patients under 18 in a remote consultation
The legal test, in plain terms.
Industry analysis
Compounded peptides and GLP-1s: the US–UK regulatory divergence
The US peptide landscape is restricted — and moving.
Clinics
How to add a private blood testing service to a UK telehealth clinic in 2026: phlebotomy, labs, and acting on results
Why blood testing complements telehealth.
Brands
How to launch a UK acid reflux and GORD telehealth service in 2026: PPIs, red flags, and safe long-term use
Why reflux suits telehealth.
Brands
How to launch a UK gout telehealth service in 2026: acute flares, urate-lowering therapy, and monitoring
Why gout is a two-part problem.
Clinics
How to launch a UK sleep and insomnia telehealth service in 2026: zopiclone, melatonin, and safe remote prescribing
The sleep market opportunity for UK telehealth operators.
Industry analysis
Pharmacy First and private telehealth in the UK in 2026: where the NHS scheme meets private services
What Pharmacy First actually is.
Brands
Launching a UK thyroid and hypothyroidism telehealth service in 2026: levothyroxine, monitoring, and safe titration
Why thyroid is a monitoring model.
Brands
How to launch a UK UTI and cystitis telehealth service in 2026: antibiotics, stewardship, and safe remote treatment
Why UTI suits telehealth — with limits.
Compliance
The NHS Data Security and Protection Toolkit (DSPT) for UK telehealth: who needs it and how to complete it
What the DSPT actually is.
Operations
Medicines waste and returns in UK telehealth: handling unused, returned, and recalled stock
Why medicines waste is an operator problem.
Brands
How to launch a UK migraine telehealth service in 2026: triptans, prevention, and safe remote prescribing
Why migraine suits telehealth.
Operations
Out-of-hours cover and clinical continuity for UK telehealth in 2026: what good looks like
Why out-of-hours is a patient-safety issue.
Brands
How to launch a UK allergy and hay fever telehealth service in 2026: antihistamines, nasal steroids, and referral limits
Why allergy suits telehealth.
Patient Safety
Safeguarding in UK telehealth: building a remote-consultation safeguarding process that holds up
Why remote consultations make safeguarding harder.
Compliance
Age and identity verification for restricted medicines in UK telehealth in 2026
Why verification is the compliance fault line.
Operations
Electronic prescriptions in UK private telehealth: EPS, tokens, and how private prescribing flows in 2026
EPS is an NHS system — what that means for private operators.
Brands
Launching a UK asthma and respiratory telehealth service in 2026: inhalers, reviews, and safety-netting
The case for respiratory telehealth.
Clinics
How to add a travel health and vaccination service to a UK telehealth clinic in 2026
Why travel health suits a hybrid telehealth clinic.
Brands
How to launch a UK smoking cessation telehealth service in 2026: varenicline, NRT, and the prescribing map
Where smoking cessation telehealth fits in the UK market.
Compliance
DPIA template for UK telehealth: what to include and how to write one that survives inspection
When a DPIA is mandatory for UK telehealth.
Industry analysis
NHS + private UK telehealth partnerships in 2026: the channel opportunity operators are missing
Why the NHS channel is more accessible than most operators assume.
Compliance
UK telehealth cybersecurity essentials in 2026: what operators need to prioritise
Why UK telehealth is a rich target.
Operations
Handling a UK telehealth patient complaint: an end-to-end operator playbook
The regulatory frame around UK telehealth complaints.
Industry analysis
UK telehealth M&A in 2026: how brands should think about acquisition and exit
What's driving UK telehealth M&A activity in 2026.
Operations
UK telehealth analytics in 2026: what to measure and what to ignore
Metrics that drive strategic decisions.
Operations
Pricing transparency on UK telehealth landing pages: what converts and why
Why hidden pricing kills conversion in UK telehealth 2026.
Brands
Multi-brand UK telehealth strategy: when to launch a second brand under one operator
Why operators consider a second brand.
Patient Safety
Yellow Card reporting workflow for UK telehealth: what operators should build
What the Yellow Card scheme actually is.
Industry analysis
Q3 2026 priorities for UK telehealth operators: what to focus on this quarter
The oral GLP-1 rollout window is a Q3 priority for weight management.
Industry analysis
UK telehealth H1 2026 in review: what worked, what didn't, what changed
Oral semaglutide arrived and reshaped the weight management category.
Compliance
How to write clinical SOPs for UK telehealth: a practical operator's guide
What SOPs actually are — and what they're not.
Industry analysis
How UK patients find and choose a telehealth service in 2026: research for operators
Where patients search has shifted.
Industry analysis
UK telehealth in H2 2026: outlook for operators heading into the second half
Oral GLP-1 reshapes the weight management opportunity.
Compliance
UK telehealth marketing under MHRA and ASA in 2026: what's allowed and what isn't
The rulebook — three sources operators need to know.
Brands
The first 90 days operating a UK telehealth brand: what actually happens
Days 1-14 — the initial conversion surprise.
Industry analysis
Online doctor vs online pharmacy in the UK in 2026: what's the difference?
What an online doctor actually is — the regulated definition.
Brands
Switching patients from injectable to oral GLP-1 in UK telehealth: pathway considerations
Patient demand for the switch is real — but the call sits with the prescriber.
Industry analysis
Oral semaglutide and the Wegovy pill: what it means for UK telehealth in 2026
What changes operationally — and what doesn't.
Brands
How to launch a UK weight management brand using oral GLP-1 (Wegovy pill) in 2026
Why oral makes 2026 the right launch window.
Clinics
How to add GLP-1 weight management to a UK clinic in 2026 (oral and injectable)
Why adding GLP-1 now is the right move.
Regulation
Can I run a UK telehealth service from outside the UK?
The regulated layer must be UK-based.
Regulation
What is the Falsified Medicines Directive status in UK pharmacy in 2026?
Where the EU FMD applies in 2026.
Operations
How are private prescription prices set in the UK in 2026?
The three or four components of a private prescription price.
Compliance
What is shared care in UK private prescribing and when does it apply?
What shared care actually means.
Regulation
Do I need a wholesale dealer's licence to start a UK telehealth brand?
What a WDA is and who needs one.
Operations
How does NHS prescription work alongside a private UK telehealth service?
Shared care — private initiation, NHS continuation.
Industry analysis
What is the difference between a private clinic and a digital clinic in the UK in 2026?
The fundamental operational distinction.
Regulation
Can I market my UK telehealth service to patients outside the UK?
Why this is harder than UK domestic operation.
Compliance
What records do I need to keep for a UK telehealth service?
Clinical records — the core requirement.
Operations
What insurance do I need for a UK telehealth business in 2026?
Professional indemnity — the clinical cover.
Operations
How much does it cost to launch a UK telehealth brand in 2026?
The build-vs-partner question dominates the budget.
Regulation
Can I sell prescription medicines online in the UK without owning a pharmacy?
The regulated activity is dispensing — not the patient relationship.
Compliance
How long does GPhC pharmacy premises registration take in the UK?
The application is one part of a larger project.
Regulation
What is a superintendent pharmacist and do I need one for my UK telehealth brand?
What the superintendent pharmacist actually does.
Operations
How do I find a UK dispensing pharmacy partner for my telehealth brand?
Confirm GPhC registration and standing first.
Regulation
Can pharmacists prescribe in the UK in 2026?
Independent prescribing pharmacist qualification.
Compliance
What is a Patient Group Direction (PGD) and when do UK telehealth services use one?
What a PGD is and when it applies.
Regulation
Can I import medicines into the UK for my private telehealth service?
Why this question matters in UK telehealth.
Compliance
What is the difference between licensed, off-label, and Specials medicines in UK telehealth?
Licensed medicines — the default.
Operations
How do UK telehealth services verify patient identity online in 2026?
Why identity verification matters in regulated telehealth.
Brands
How to launch a UK mental health telehealth service in 2026
Why mental health is the most regulated telehealth vertical.
Brands
How to launch a UK sexual health and STI testing telehealth service in 2026
Why sexual health telehealth has scaled — and where NHS leaves gaps.
Clinics
How to add online contraception prescribing to a UK clinic in 2026
Why contraception suits remote care.
Brands
How to launch a UK hair loss telehealth service in 2026: finasteride, minoxidil, and the regulatory map
Why hair loss is a foundational UK telehealth category.
Brands
How to launch a UK dermatology telehealth service in 2026: acne, eczema, rosacea
Why dermatology suits remote care — and where it does not.
Clinics
How to set up a UK aesthetic prescribing service in 2026: regulation, prescriber model, and dispensing
Why aesthetic prescribing is its own category.
Brands
How to launch a UK ED telehealth service in 2026: the regulatory and operational brief
Why ED is a foundational telehealth category in the UK.
Brands
How to launch a UK HRT clinic online in 2026: regulatory, clinical, and operational brief
Why HRT online is a defensible category — evidence, demand, NHS gap.
Compliance
CQC registration for UK telehealth services: who needs it, who doesn't, and how to register
What CQC actually regulates — the 'regulated activities' list.
Brands
How to launch a telehealth brand in the UK in 2026: the operator’s checklist
Step 1: pick the category and check regulatory feasibility before anything else.
Brands
Choosing a white-label telehealth platform in the UK: what to include in your shortlist
What 'white-label' actually means in UK telehealth.
Dispensing
Cold-chain dispensing for UK telehealth: GLP-1, biologics, and what most operators get wrong
What cold-chain actually requires under UK GDP — 2-8°C, monitored, audited.
Regulation
MHRA enforcement trends 2024-2026: what UK telehealth operators are getting caught on
The shift from sporadic to systematic — what changed in 2024.
AI & Clinical Decision Support
AI in UK telehealth 2026: where it works, where it does not, and the MHRA medical-device line
Where AI works in UK telehealth right now.
Patient Safety
Adverse event management and pharmacovigilance for UK telehealth operators
What pharmacovigilance actually means for telehealth operators.
Dispensing
Same-day dispensing in UK telehealth: what it actually takes operationally
What 'same-day' means in regulated UK dispensing — and what it doesn't.
Customer Support Operations
Scaling customer support in UK telehealth: tier structure, escalation, clinical triage
Why telehealth support is not standard ecommerce support.
Regulation
UK pharmacy regulation in 2026: GPhC, MHRA, CQC, ICO — what each one actually does for telehealth
GPhC — the pharmacy regulator and what 'fit for purpose' actually means.
People & Workforce
Hiring and retaining clinical staff for UK telehealth in 2026
The UK clinical workforce reality — supply, demand, regulatory geography.
Financial Operations
UK telehealth payments, refunds, and chargebacks: a financial operations guide
The UK telehealth payment stack — Stripe, PayPal, BNPL.
Engineering
Building a telehealth API integration that doesn't fall over: a UK operator's guide
What integrations actually matter — CRM, EMR, payments, dispensing partner.
Patient Experience
Patient retention in UK telehealth: what works beyond the first prescription
The retention reality — UK telehealth has higher one-and-done rates than most operators admit.
Operations
The UK telehealth operations stack in 2026: build, buy, or partner
The six layers of a UK telehealth stack — what they actually are.
Operations
UK pharmacy operating costs in 2026: a transparent breakdown
Premises — the visible fixed cost.
Brands
White-label vs in-house pharmacy: the real cost breakdown
Capital cost: GPhC fit-out, equipment, software, licensing.
Clinics
Switching dispensing providers without losing patients
Common reasons clinics switch — service quality, pricing, tech, regulatory.
Brands
Build vs partner: when should a UK brand actually build their own pharma infra?
The honest cost of building each layer (clinical, intake, dispensing, portal) yourself.
Brands
Taking a UK telehealth brand to US and EU markets
Why brands cross borders — TAM, margin, brand defensibility.
Brands
Customer acquisition for UK telehealth brands: paid vs organic
Channels that actually work for UK pharma — Meta, Google, TikTok, Reddit, content.
Clinics
Same-day dispatch logistics in UK pharma: how it actually works
The five steps inside a same-day dispatch — order in, clinical check, picking, packing, courier hand-off.
Brands
Scaling a UK telehealth brand from launch to 10k patients
What breaks first at 500 patients vs 5,000 vs 10,000.
Clinics
Choosing a dispensing partner for your UK clinic: what to ask
Why most UK clinics outgrow in-house dispensing within 12 months.
Brands
White-label telehealth platforms compared: pricing, control, risk
Why white-label became the dominant launch path in UK telehealth 2024-2026.
Brands
Marketing compliance for UK telehealth: what the ASA and CAP allow
How the UK advertising regulator stack actually works (ASA, CAP, ad platforms).
Brands
How to launch a UK weight management clinic with GLP-1 in 2026
Category regulatory landscape — NICE, MHRA, GPhC overlap.
Brands
UK telehealth regulatory checklist for first-time brand founders
Map the layers and which regulator owns each.
Industry analysis
Pharmacy-as-a-service: the rise of headless pharmacy infrastructure for UK telehealth
What pharmacy-as-a-service actually is.
Clinics
How to add online prescribing to an existing UK clinic in 2026
Why clinics add online prescribing — and what changes when you do.
Clinics
The admin client care fee model explained — what clinics actually receive
What an admin client care fee actually is — and what it isn't.
Clinics
Multi-location clinic operations: dispatch coordination at scale
The operational problems unique to running 3+ clinic sites.
Operations
UK telehealth platform pricing in 2026: what you should pay, what is worth paying for
The four pricing structures in UK telehealth platforms.
Brands
How to scale a UK telehealth brand from 1,000 to 100,000 patients
1,000 to 5,000 patients — the clinical capacity transition.
Clinics
Preparing for a GPhC inspection: a clinic owner's checklist
How GPhC inspections work — announced, unannounced, themed.
Clinics
Controlled drugs and remote prescribing: the GPhC and CQC rules
Which drugs are controlled — Schedule 2 through 5.
Telehealth Operations
Building a women's-health telehealth vertical in the UK
The categories — contraception, menopause/HRT, fertility, PCOS, weight management.
Industry analysis
Best UK telehealth platforms in 2026: independent buyer's comparison
Five categories of UK telehealth platform.
Telehealth Operations
Building a men's-health telehealth vertical in the UK
The categories — ED, hair loss, TRT, premature ejaculation, mental health.
Telehealth Operations
ADHD telehealth in the UK: navigating shared-care and CD rules
The current UK ADHD diagnostic and treatment pathway.
Industry analysis
PExpo review 2026: what is PExpo, how it works, and who it's for
What PExpo is.
Telehealth Operations
HRT prescribing online in the UK: what clinicians need to know
The HRT market in the UK — patient demand, supply, NHS HRT-PPC.
Telehealth Operations
GLP-1 dispensing in the UK: compounded vs commercial, supply, ethics
The current UK supply landscape for GLP-1 medications (Wegovy, Mounjaro, Ozempic).
Industry analysis
How do online pharmacies make money in the UK? The unit economics explained
The four revenue streams.
Compliance
CQC registration for digital clinics: when you need it
What 'regulated activities' under CQC actually means.
Compliance
GPhC superintendent pharmacist: responsibilities and accountability
Statutory role definition — what the law actually requires.
Clinics
How to start a private GP service in the UK in 2026
Why private GP services are scaling in 2026.
Compliance
ASA and CAP rules for UK pharma adverts: what trips brands up
Who ASA and CAP are and how they relate.
Compliance
MHRA distance-selling rules: what you can and can't do online
What 'distance selling' covers in the MHRA framework.
Compliance
UK GDPR for telehealth: lawful bases, retention, special-category data
Why telehealth defaults to special-category data under Article 9.
Operations
Top UK dispensing pharmacy partners for telehealth brands in 2026
Three categories of UK dispensing partner.
Industry analysis
GLP-1 supply chain in the UK: bottlenecks, alternatives, outlook
Where UK GLP-1 supply comes from — manufacturers, importers, MHRA approvals.
Industry analysis
NHS vs private UK telehealth: where the lines are
The boundary — what NHS does, what private telehealth fills.
Industry analysis
Direct-to-consumer pharma in the UK in 2026: the operator playbook
How UK DTC pharma got here.
Industry analysis
The future of UK pharma platforms: where the industry is heading
What the platform layer enabled — fewer barriers to launching a brand, faster compounding access.
Industry analysis
UK telehealth platform landscape: who does what
The five platform archetypes operating in UK telehealth today.
Operations
What is dispensing in UK telehealth? A foundational guide
Dispensing is a regulated activity — not a logistics function.
Industry analysis
UK telehealth market 2026: what's working, what's broken
Market sizing — patient volume, revenue, growth trajectory.